Research > ETFs > ETF / ETP Commentary > 

Pairing Quality Growth & High Yields: A Blueprint for All-Weather Portfolios

Investors often treat growth and dividends as opposing camps, but in practice, this means the two can complement each other.This is especially true when each sleeve follows its own rules-based process. The WisdomTree U.S. Quality Growth Fund (QGRW B-) and the WisdomTree U.S. High Dividend Fund (DHS A-) offer one way to combine them.Key Takeaways: Combining a growth fund like QGRW with a high-dividend fund like DHS balances tech-driven capital appreciation with reliable income. QGRW heavily concentrates in megacap technology, whereas DHS avoids the Magnificent Seven in favor of defensive value sectors like financials and healthcare. Pairing both strategies provides a disciplined hedge against shifting market leadership between growth rallies and value cycles. QGRW, which manages $1.86 billion, marks its third anniversary in December. Over these three years, the fund has returned nearly 140%, easily beating the 112% generated by the S&P 500 Growth Index. As the names of these ETFs suggest, QGRW is an alternative to traditional large-cap growth offerings. The fund tracks the WisdomTree U.S. Quality Index and holds roughly 100 large- and-midcap U.S. companies. DHS tracks the WisdomTree U.S. High Dividend Index, which provides exposure to the highest-yielding companies domestically, with an expense ratio of 38 basis points.The Growth SleeveFor QGRW, its index’s stocks are ranked on an equally weighted composite of growth and quality factors. The fund, which launched in December 2022, carries a 0.28% expense ratio. The index starts with the 500 largest U.S. companies and applies its ranking methodology. It then keeps the top 100, weights them by market cap, and rebalances in June and December. Technology makes up half of the fund’s portfolio at 51.67%, with communication services, consumer discretionary, industrials, and healthcare adding another 41.67% more. As of October 26, its top three holdings are Nvidia Corp. (12.29%), Microsoft Corp. (10.25%), and Google Inc. (7.1%). So far, this concentration seems to be paying off. The fund has returned 15.44% year-to-date, beating the 10.42% average of competitors in its category, according to VettaFi data. It also outperformed its peers for the one-year period by 5.83%, with a 16.81% return, compared to a category average of 10.98%.The Income SleeveDHS, which has an expense ratio of 0.38%, has been around since 2006 and focuses on the highest-yielding companies in the WisdomTree U.S. Dividend Index. The fund’s portfolio looks very different from QGRW’s, because due to its methodology, it largely avoids the Magnificent Seven and leans toward sectors like financials, healthcare, consumer staples, and energy. DHS’s has slightly outperformed QGRW when we look at year-to-date and one-year figures, returning 17.61% and 19.87%, respectively.A Balanced PairingQGRW and DHS approach the market from opposite directions, which is what makes them a natural pair. The former screens for quality growth and delivers concentrated exposure to the market’s most profitable innovators, which has led to strong returns and a higher valuation. Meanwhile, DHS screens for yield and weights by projected dividends, producing a broader, cheaper portfolio with a 3.18% yield and steady dividend growth. Pairing the two funds allows investors the opportunity to participate in growth while collecting income that doesn’t depend on market-cap-driven rallies. When market leadership rotates between growth and value or income, one sleeve may help offset the other. Allocations should reflect each investor’s goals and risk tolerance, but the pairing of QGRW and DHS offers a straightforward way to balance both. For more news, information, and analysis, visit the Modern Alpha Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.